https://tee-labs.com/en/2021/12/20/hello-world-2/2025-07-25T14:12:42+08:00https://tee-labs.com/en/2021/12/06/tee-labs-x-elite/2025-07-25T14:29:53+08:00https://tee-labs.com/en/2021/07/22/tee-labs-opens-first-phase-of-incubation-camp-competition/2025-07-25T14:21:58+08:00https://tee-labs.com/en/2021/09/16/tee-labs-officially-opens-for-business/2025-07-25T10:43:50+08:00https://tee-labs.com/en/2021/10/20/tee-labs-incubatee-shouti-successfully-raises-100-million-in-series-b-financing/2025-07-25T13:40:35+08:00https://tee-labs.com/en/2022/05/26/tee-labs-incubatee-%ef%bc%9afull-life-technologies-completes-37-million-usdseries-a-financing/2025-07-25T13:11:42+08:00https://tee-labs.com/en/2022/06/19/tee-labs-incubatee-hearthill-successfully-completes-chinas-longest-pvad-animal-study/2025-07-25T14:04:26+08:00https://tee-labs.com/en/2022/08/05/tee-labs-incubatee-shouti-announces-change-of-companys-english-name-and-receives-33-million-oversubscription/2025-07-24T17:36:55+08:00https://tee-labs.com/en/2022/08/15/tee-labs-recognized-as-innovative-incubator-in-pudong-new-area/2025-07-25T11:04:14+08:00https://tee-labs.com/en/2022/09/14/tee-labs-incubatee-full-life-technologies-conjugates-beyond-adcs-there-are-also-rdcs/2025-07-25T13:27:23+08:00https://tee-labs.com/en/2022/11/30/tee-labs-incubatee%ef%bc%9afull-life-technologies-to-acquire-focus-x-therapeutics-bolstering-peptide-focused-radiopharmaceutical-pipeline/2025-07-25T11:34:19+08:00https://tee-labs.com/en/2024/11/25/tee-labs-incubated-company-linzight-technology-grand-opening/2025-07-25T14:39:40+08:00https://tee-labs.com/en/2024/10/25/tee-labs-incubated-company-hearthill-medicalcompletes-china-first-implantation-of-polymer-surgical-aortic-valve/2025-07-25T14:39:52+08:00https://tee-labs.com/en/2024/06/12/tee-labs-incubated%ef%bc%9ainnostellar-biotherapeutics-completes-series-b-funding-to-advance-gene-therapy-rd-and-industrialization/2025-07-25T13:32:35+08:00https://tee-labs.com/en/2024/07/04/tee-labs-portfolio-company-fusion-biosciences-tumor-microenvironment-targeting-bispecific-antibody-fusion-protein-fs-8002-gains-clinical-approval/2025-07-25T14:39:25+08:00https://tee-labs.com/en/2024/06/05/shanghai-headquarter-enterprise-development-association-zhangjiang-branch-officially-established-ni-lin-of-tee-labs-appointed-secretary-general/2025-07-23T16:10:48+08:00https://tee-labs.com/en/2024/06/01/tee-labs-incubated-company-full-life-technologies-announces-fda-approval-of-ind-application-for-new-drug-%c2%b2%c2%b2%e2%81%b5ac-fl-020/2025-07-25T14:38:09+08:00https://tee-labs.com/en/2024/06/04/tee-labs-partner-an-interview-with-academician-yuan-junying/2025-07-23T16:05:07+08:00https://tee-labs.com/en/2024/01/04/tee-labs-incubatee-full-life-technology-series-b-funding/2025-07-23T16:16:13+08:00https://tee-labs.com/en/2023/10/11/pudong-new-area-highlights-tee-labs-supporting-scientific-innovation-from-0-to-1-nurturing-biotech-startups/2025-07-23T16:14:08+08:00https://tee-labs.com/en/2023/08/03/accelerating-global-collaboration-tee-labs-and-mtpc-enterprise-matchmaking-meeting-helps-innovative-pharmaceutical-companies-go-global/2025-07-24T17:42:48+08:00https://tee-labs.com/en/2023/02/03/tee-labs-a-biomedical-professional-incubator-sees-its-first-incubated-company-structure-therapeutics-successfully-listed-on-the-us-stock-exchange/2025-07-25T11:14:26+08:00